EFFECT OF ENDOTHELIN-1 INFUSION ON THE DEVELOPMENT OF INTIMAL HYPERPLASIA AFTER BALLOON CATHETER INJURY

Citation
Jd. Trachtenberg et al., EFFECT OF ENDOTHELIN-1 INFUSION ON THE DEVELOPMENT OF INTIMAL HYPERPLASIA AFTER BALLOON CATHETER INJURY, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000355-190000359
Citations number
30
Categorie Soggetti
Cardiac & Cardiovascular System","Respiratory System","Pharmacology & Pharmacy
ISSN journal
01602446
Volume
22
Year of publication
1993
Supplement
8
Pages
190000355 - 190000359
Database
ISI
SICI code
0160-2446(1993)22:<190000355:EOEIOT>2.0.ZU;2-E
Abstract
Previous studies have shown endothelin-1 (ET-1) to be mitogenic for sm ooth-muscle cells. We explored in vivo the ability of high ET-1 levels to worsen angioplasty restenosis. Left carotid artery balloon endothe lial denudation was performed on 14 rats. ET-1 was delivered via osmot ic pump at a rate of 5 pmol/kg/min. Intimal development and plasma ET- 1 levels were assessed at 2 weeks. Blood pressure and heart rate were measured throughout the study. For analysis, the animals were divided into three groups based on ET-1 levels at harvest: control, 4.3 = 0.5 pmol/ml (n = 6); low ET-1, 5.2 +/- 0.9 pmol/ml (n = 4); and high ET-1, 23.1 +/- 5.9 pmol/ml (n = 4). Although ET-1 infusion caused blood pre ssure elevation in both ET-1 groups, this was more marked and prolonge d in the group with a high ET-1 level at study conclusion. Evaluation of the intimal:medial area ratio showed a marked increase in intimal t hickness in the high ET-1 group versus control (1.13 +/- 0.23 versus 0 .35 +/- 0.11; p<0.05). We conclude that ET-1 infusion in responsive an imals can cause worsening of the intimal hyperplastic response after m echanical injury. Further study is required to elucidate whether this is entirely caused by a direct effect of ET-1 on smooth-muscle cell mi togenesis or is also by the hemodynamic effects of ET-1-induced hypert ension, or an effect of another mediator released in response to the E T-1 (e.g., angiotensin II).